Liu Nianli相关文献与解析，生知库 | 链接生命科学的每一步

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma.

RBM34 的过度表达促进肿瘤进展，并与肝细胞癌的不良预后相关

期刊:Journal of Clinical and Translational Hepatology

影响因子:4.2

doi:10.14218/JCTH.2022.00166

Wang Wei, Zhang Rui, Feng Ning, Zhang Longzhen, Liu Nianli

Systematic pan-cancer analysis identifies RBM39 as an immunological and prognostic biomarker

系统性泛癌分析发现RBM39是一种免疫学和预后生物标志物。

期刊:Journal of Cellular and Molecular Medicine

影响因子:4.2

doi:10.1111/jcmm.17517

Zhang, Rui; Wang, Wei; Zhang, Nie; Chen, Xueting; Liu, Wanming; Zhang, Longzhen; Liu, Nianli

MBD2 Correlates with a Poor Prognosis and Tumor Progression in Renal Cell Carcinoma

MBD2与肾细胞癌预后不良和肿瘤进展相关

期刊:Oncotargets and Therapy

影响因子:2.8

doi:10.2147/OTT.S256226

Li, Liantao; Li, Na; Liu, Nianli; Huo, Fuchun; Zheng, Junnian

H1/pAIM2 nanoparticles exert anti-tumour effects that is associated with the inflammasome activation in renal carcinoma

H1/pAIM2纳米颗粒发挥抗肿瘤作用，这与肾癌中炎症小体的激活有关。

期刊:Journal of Cellular and Molecular Medicine

影响因子:4.2

doi:10.1111/jcmm.13842

Chai, Dafei; Liu, Nianli; Li, Huizhong; Wang, Gang; Song, Jingyuan; Fang, Lin; Lu, Zheng; Yao, Hong; Zheng, Junnian

ISG12a Restricts Hepatitis C Virus Infection through the Ubiquitination-Dependent Degradation Pathway

ISG12a通过泛素依赖性降解途径限制丙型肝炎病毒感染

期刊:Journal of Virology

影响因子:3.8

doi:10.1128/JVI.00352-16

Xue, Binbin; Yang, Darong; Wang, Jingjing; Xu, Yan; Wang, Xiaohong; Qin, Yuwen; Tian, Renyun; Chen, Shengwen; Xie, Qinya; Liu, Nianli; Zhu, Haizhen

2-octynoic acid inhibits hepatitis C virus infection through activation of AMP-activated protein kinase

2-辛炔酸通过激活AMP活化蛋白激酶抑制丙型肝炎病毒感染。

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0064932

Yang, Darong; Xue, Binbin; Wang, Xiaohong; Yu, Xiaoyan; Liu, Nianli; Gao, Yimin; Liu, Chen; Zhu, Haizhen

Notch-Driven Cholangiocarcinogenesis Involves the Hippo Pathway Effector TAZ via METTL3-m6A-YTHDF1.

Notch 驱动的胆管癌发生涉及 Hippo 通路效应因子 TAZ，该通路通过 METTL3-m6A-YTHDF1 发挥作用

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma.

RBM34 的过度表达促进肿瘤进展，并与肝细胞癌的不良预后相关

Systematic pan-cancer analysis identifies RBM39 as an immunological and prognostic biomarker

系统性泛癌分析发现RBM39是一种免疫学和预后生物标志物。

MBD2 Correlates with a Poor Prognosis and Tumor Progression in Renal Cell Carcinoma

MBD2与肾细胞癌预后不良和肿瘤进展相关

H1/pAIM2 nanoparticles exert anti-tumour effects that is associated with the inflammasome activation in renal carcinoma

H1/pAIM2纳米颗粒发挥抗肿瘤作用，这与肾癌中炎症小体的激活有关。

ISG12a Restricts Hepatitis C Virus Infection through the Ubiquitination-Dependent Degradation Pathway

ISG12a通过泛素依赖性降解途径限制丙型肝炎病毒感染

2-octynoic acid inhibits hepatitis C virus infection through activation of AMP-activated protein kinase

2-辛炔酸通过激活AMP活化蛋白激酶抑制丙型肝炎病毒感染。